Cuthbert Simpkins on reducing the bioavailability of nitric oxide to improve patient survival

Cuthbert Simpkins, President and Chief Innovation Officer at Vivacelle Bio, Inc. talks to us about the origin of Vivacelle Bio. He mentions how despite being able to fix physical injury, death can still occur due to an overproduction of nitric oxide, which acts as a blood vessel dilator. Stopping nitric oxide from being produced, clamps down blood flow allowing a better chance of survival. The challenge is to reduce the bioavailability of nitric oxide, while at the same time allowing its production.

videos giant health 2016
TOP

We'd love to work with you

Contact Us
London

16-17 Little Portland Street
London
W1W 8BP

+44 (0)20 7291 5070
email

Singapore

8 Cross Street, Level 28
PWC Building
Singapore, 048424

+44 (0)20 7291 5070
email

Suffolk Coast

Basepoint Unit 12a
The Havens
Ransomes Euro Park
Ipswich, IP3 9BF

T. +44 (0)1473 722 794
email

Call Us